NASDAQ:ALGN - Nasdaq - US0162551016 - Common Stock - Currency: USD
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Align Technology (NASDAQ:ALGN) and its peers.
Mentions: XRAY
A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could worsen the already wide US fiscal deficit. A poor auction for 20-year U.S. Treasury bonds further raised concerns, as weak demand implies investors are becoming more cautious about holding long-dated U.S. debt.
An analyst reduced his price target on the Chinese e-commerce company. Early Thursday morning, an analyst made a relatively assertive price target cut on the stock, and the market reacted by trading it down by almost 4% on the day. Well before market open that session, Susquehanna International's Shyam Patil reduced his JD.com price target by more than 10%, cutting it to $40 per share from his previous $45.
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
ConocoPhillips believes it's a clear leader in the oil patch. Its leading low-cost resource base enables it to generate substantial cash flow in the current environment. Two notable growth drivers have it on track to deliver leading free cash flow growth through 2029.
Cardinal Health, Labcorp and Align Technology have been highlighted in this Industry Outlook article.
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against other best pharma stocks to invest in now amid the domestic manufacturing boom. Trump Incentivizes Pharmaceuticals to Build Domestic Manufacturing […]
We recently published a list of Billionaire Ken Griffin’s 10 Midcap Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Align Technology, Inc. (NASDAQ:ALGN) stands against Billionaire Ken Griffin’s other midcap stock picks with huge upside potential. Ken Griffin, the founder of Citadel, is an influential albeit […]
We recently published a list of Billionaire Ken Griffin’s 10 Midcap Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Block, Inc. (NYSE:XYZ) stands against Billionaire Ken Griffin’s other midcap stock picks with huge upside potential. Ken Griffin, the founder of Citadel, is an influential albeit controversial […]
Here we discuss three stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, LH and ALGN.
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
Corporate buybacks surged in April, led by Apple, Alphabet, and Wells Fargo, signaling confidence and boosting stock prices. Tech and consumer companies also joining the buyback binge.
ALGN vs. SAUHY: Which Stock Is the Better Value Option?
The average of price targets set by Wall Street analysts indicates a potential upside of 31.4% in Align Technology (ALGN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Align Technology (ALGN) delivered earnings and revenue surprises of 7.58% and 0.67%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: XRAY
The continued solid uptake of Cardinal Health's products is expected to have driven fiscal third-quarter revenues despite an uncertain macroeconomic environment.
Here is a sneak peek into how these three MedTech stocks, ALGN, TNDM and ICLR, may fare in their quarterly results, slated to be released tomorrow.
McEvoy, the former leader of Johnson & Johnson’s medtech business, started immediately. Jim Hollingshead, who was CEO of Insulet for three years, resigned on Monday but will work as a consultant.